JWN
48
6
HBI
59
4
KLAC
47
4
R
71
4
NOC
43
11
NVDA
56
-4
GE
67
2
HCP
66
8
APD
59
2
JPM
69
2
VRSN
53
-4
SNA
68
-2
FLR
58
3
A
43
2
NDAQ
62
2
GS
75
2
MAS
58
2
ISRG
74
-2
MRK
25
-2
CAH
48
-5
JWN
48
6
HBI
59
4
KLAC
47
4
R
71
4
NOC
43
11
NVDA
56
-4
GE
67
2
HCP
66
8
APD
59
2
JPM
69
2
VRSN
53
-4
SNA
68
-2
FLR
58
3
A
43
2
NDAQ
62
2
GS
75
2
MAS
58
2
ISRG
74
-2
MRK
25
-2
CAH
48
-5
Financhill
Back

ProPhase Labs Vs. OncoCyte Industry Stock Comparison

Sell
18

PRPH
ProPhase Labs

Last Price:
0.77
Seasonality Move:
13.45%
Sell
45

OCX
OncoCyte

Last Price:
2.70
Seasonality Move:
42.9%
Sell
18
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.77. The Score for PRPH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.71. The Score for OCX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight selling pressure.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight selling pressure.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 19.19 Sell
Chaikin Money Flow: -29840 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.83 - 2.31) Sell
Bollinger Bands (100): (1.73 - 3.13) Sell

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 41.8 Sell
Chaikin Money Flow: -8651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.73 - 3.07) Sell
Bollinger Bands (100): (2.89 - 3.21) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.77 Buy
20-day SMA: 1.37 Sell
50-day SMA: 1.97 Sell
200-day SMA: 3.81 Sell
8-day EMA: 0.84 Sell
20-day EMA: 1.24 Sell
50-day EMA: 1.83 Sell
200-day EMA: 3.39 Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.71 Buy
20-day SMA: 2.86 Sell
50-day SMA: 2.97 Sell
200-day SMA: 2.94 Sell
8-day EMA: 2.72 Sell
20-day EMA: 2.82 Sell
50-day EMA: 2.93 Sell
200-day EMA: 3.2 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):